Position in IDYA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,672,529
-$631,495 QoQ
Shares Held
230,268
-4.1% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 99.22394774784165.ToString("F0")%
Shared 0.ToString("F0")%
None 0.7760522521583546.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,057,408,835 across 166 Biotechnology names. IDYA ranks #77 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in IDYA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,672,529 | 230,268 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,304,024 | 240,209 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $6,405,913 | 235,425 | Shares | Defined | 2025-11-13 | |
| 2024-06-30 | $1,113,864 | 31,725 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,133,155 | 25,824 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $969,090 | 27,237 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $700,858 | 25,977 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $523,109 | 22,260 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||